Stimcell Energetics (STME) Cash from Financing Activities (2011 - 2026)
Stimcell Energetics' (STME) quarterly Cash from Financing Activities came in at $50000.0 in Q1 2026, up 198.6% year-on-year from $16745.0 in Q1 2025, and down 56.24% quarter-over-quarter from $114248.0 in Q4 2025.
Stimcell Energetics (STME) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Stimcell Energetics' Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $50000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 198.6% year-over-year to $50000.0 in Q1 2026; TTM through Feb 2026 was $330361.0, a 672.27% increase from a year earlier, with the FY2025 full-year figure at $112858.0, up 23.97% from the prior year.
- Cash from Financing Activities eased to $50000.0 in Q1 2026 per STME's latest filing, from $114248.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $116377.0 in Q2 2023 and bottomed at -$3967.0 in Q2 2024.
- The 5-year median for Cash from Financing Activities is $78686.0 (2022), against an average of $70257.1.
- Across the five-year window, Cash from Financing Activities tumbled 103.41% in 2024 and surged 1766.57% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at $76372.0 in 2022, then jumped by 52.38% to $116377.0 in 2023, then tumbled by 74.22% to $30000.0 in 2024, then surged by 280.83% to $114248.0 in 2025, then plunged by 56.24% to $50000.0 in 2026.
- Per Business Quant, the three latest STME Cash from Financing Activities figures stand at $50000.0 (Q1 2026), $114248.0 (Q4 2025), and $100000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 50,000.00 |
| Feb 28, 2026 | 50,000.00 |
| Nov 30, 2025 | 114,248.00 |
| Nov 30, 2025 | 114,248.00 |
| Aug 31, 2025 | 100,000.00 |
| Aug 31, 2025 | 100,000.00 |
| May 31, 2025 | 66,113.00 |
| May 31, 2025 | 66,113.00 |
| Feb 28, 2025 | 16,745.00 |
| Feb 28, 2025 | 16,745.00 |
| Nov 30, 2024 | 30,000.00 |
| Nov 30, 2024 | 30,000.00 |
| May 31, 2024 | -3,967.00 |
| May 31, 2024 | -3,967.00 |
| Feb 29, 2024 | 95,000.00 |
| Feb 29, 2024 | 95,000.00 |
| May 31, 2023 | 116,377.00 |
| May 31, 2023 | 116,377.00 |
| Feb 28, 2023 | 92,615.00 |
| Feb 28, 2023 | 92,615.00 |